Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated

Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated

Lakefront Biotherapeutics NV shares dropped 2.7% to 23.80 euros in Amsterdam on Monday. In New York, its Nasdaq ADRs were off 1.7% at $27.86 early in the afternoon. The Belgian biotech, which recently took the Lakefront name, has lost about 15% this year on both markets. Lakefront is still in the early days after its Galapagos rebrand. Shareholders okayed switching the name to Lakefront Biotherapeutics and adopted the new ticker LKFT. Management wants investors to now value it as a cash-heavy acquirer and builder of oncology and immunology programs, instead of focusing on the Galapagos legacy pipeline.
June 1, 2026
Globalstar Trades Under Amazon’s $90 Bid With Confusing Deal Math

Globalstar Trades Under Amazon’s $90 Bid With Confusing Deal Math

Globalstar shares were lower midday Monday, staying under the headline $90-a-share cash option in the Amazon.com buyout. Amazon shares also dropped, taking a toll on the stock part of the deal. Globalstar was at $83.31, off 1.1%. Amazon traded at $264.18, down 2.4%. This is important now because the deal is not a pure cash offer. Globalstar holders can choose $90 in cash or 0.3210 Amazon shares for each Globalstar share, but the shares are capped at $90 in value. Cash elections are limited to 40% of Globalstar shares. If more shareholders want cash, proration will scale it back.
June 1, 2026
Co-Diagnostics Shares Drop After New Resale Filing

Co-Diagnostics Shares Drop After New Resale Filing

Co-Diagnostics shares dropped hard on the Nasdaq in early trading Monday. It was the first regular session after the U.S. Securities and Exchange Commission made effective a resale registration statement linked to a recent private placement. The share price was at $6.71, down $1.83 from the $8.53 close on Friday. The stock swung between $5.11 and $10.18 during the session. The move pointed to high volatility in the small-cap diagnostics stock.
June 1, 2026
CGCT Heads Into Key Week With Factorial Deal Nearing Nasdaq Ticker Switch

CGCT Heads Into Key Week With Factorial Deal Nearing Nasdaq Ticker Switch

Cartesian Growth Corporation III was active premarket Monday after the SPAC dropped 7.19% to $12.53 Friday. Traders looked at the shareholder-backed merger with Factorial Inc., a solid-state battery maker, but heavy redemptions hit the deal. Premarket volume was light, and a market data feed had CGCT at $13.07 as of 8:10 a.m. EDT. Cartesian is now more than a blank-check company. The SPAC—essentially a listed cash shell set up to merge with a private firm—got shareholder approval for the Factorial deal at its May 27 special meeting. That cleared the main investor hurdle before the company can go ahead with shifting the listing.
June 1, 2026
Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Inc. shares ticked up in premarket trading Monday, with the gain coming ahead of a scheduled appearance by company executives at a healthcare event later this week. The shares were at $3.30, up 4 cents, with the rare-disease drug maker’s market cap around $343 million. This was before the regular Nasdaq open; the exchange lists pre-market hours from 4:00 a.m. to 9:30 a.m. Eastern.
June 1, 2026
Carlsmed Stock Faces A Crucial Week After Friday’s Drop

Carlsmed Stock Faces A Crucial Week After Friday’s Drop

Carlsmed shares head into Monday’s U.S. premarket on the back foot after a sharp Friday drop, leaving investors to decide whether recent procedure-growth momentum is enough to steady the newly listed spine-surgery company. The stock closed Friday at $11.42, down 3.3% on the day and about 5.7% below the prior Friday’s close of $12.11. Market data put Carlsmed’s equity value at about $306 million; the shares remain roughly 24% below the $15 price set in its July 2025 initial public offering.
June 1, 2026
Huize Shares Down 50% in 2026 as Premium Growth Heads Into Monday Test

Huize Shares Down 50% in 2026 as Premium Growth Heads Into Monday Test

Huize Holding Limited was last at $1.42 in premarket quotes Monday, putting the China-based insurance tech firm down 49.4% for 2026 after opening the year at $2.81. Volume stayed light, with just 16,437 shares trading in the last quoted session. MarketBeat pegged the company’s market cap at about $14.36 million. Markets stayed open. Regular New York equity trading hours are 9:30 a.m. to 4:00 p.m. EDT. Nasdaq says the next full closing for U.S. equities is Juneteenth, June 19.
June 1, 2026
Wintergreen Acquisition Shares Stay Near Highs As KIKA Deal Looms

Wintergreen Acquisition Shares Stay Near Highs As KIKA Deal Looms

Wintergreen Acquisition Corp. ended the holiday-shortened week flat, trading near $10.35. Latest volume came in at 5,319 shares. That leaves the blank-check firm with a market cap of around $75.6 million. That's important now since Wintergreen isn’t a usual operating company. Wintergreen is a SPAC, or special purpose acquisition company, a shell that raises money in an IPO before it looks to merge with a private firm. Nasdaq marks Memorial Day, May 25, as a market holiday in 2026, with the next full U.S. market holiday Juneteenth, June 19.
June 1, 2026
Wetouch Stock Slid Into the Weekend—The Siemens Signal Traders Are Watching

Wetouch Stock Slid Into the Weekend—The Siemens Signal Traders Are Watching

Wetouch Technology Inc. heads into June under pressure after a holiday-shortened week in which its Nasdaq-listed shares fell about 13%, ending Friday’s regular session at $1.39 despite a late-week company update tied to Siemens. The stock slipped 0.7% on Friday, with 89,793 shares traded, after closing the prior Friday at $1.60. That matters now because there is no Sunday tape to judge. Nasdaq’s regular stock trading runs Monday through Friday from 9:30 a.m. to 4:00 p.m. Eastern Time, and U.S. markets were closed on Monday, May 25, for Memorial Day.
May 31, 2026
SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline

SciSparc Shares Jumped Last Week, Market Awaits Monday Deal Deadline

SciSparc Ltd. is set to open Monday with shares well above last week, after a deal report made the Nasdaq-traded drug maker one of last week’s most volatile microcap stocks. U.S. markets are open following the Memorial Day break; Nasdaq’s 2026 calendar put May 25 as a holiday. SciSparc shares finished Friday at $9.81, dropping 7.0% for the session. That left the stock up about 130% from its May 22 finish at $4.27. SciSparc didn't get there in a straight line. Shares spiked to $10.55 at the close on May 28 with 35.7 million changing hands, then volume fell to 824,800 traded on Friday, Yahoo Finance data show.
May 31, 2026
Insight Enterprises Shares Climb 8.9%, More Ahead

Insight Enterprises Shares Climb 8.9%, More Ahead

Insight Enterprises Inc. shares surged to close at $106.38 Friday, capping a holiday-shortened week with an 8.85% gain over five sessions. The Nasdaq stock advanced 2.90% Friday. Investors bought in after a Wall Street upgrade and margin gains tied to cloud and services, according to MarketScreener. U.S. equity markets didn’t open Sunday, as the week was already trimmed by the Memorial Day break on May 25. Nasdaq’s cash trading is set for weekdays from 9:30 a.m. to 4 p.m. Eastern. The next move for shares waits until Monday, June 1.
May 31, 2026
Cuprina Stock Faces a Nasdaq Clock After Reverse Split—What Comes Next

Cuprina Stock Faces a Nasdaq Clock After Reverse Split—What Comes Next

Cuprina Holdings Limited heads into the new week with its Nasdaq listing still in play after a rough Friday close. The Singapore-based biomedical company’s Class A shares finished at $2.40 on May 29, down 27.27%, the company’s stock page showed. Why it matters now: Cuprina said Nasdaq staff had determined the company’s securities would be scheduled for delisting after it failed to regain compliance with the $1.00 minimum bid price rule, an exchange requirement tied to the price buyers are willing to pay for a stock. The firm said it filed a hearing request on May 28, which keeps the shares trading while a Nasdaq Hearings Panel reviews the case.
May 31, 2026
Legend Biotech Heads Into Monday After a Rough Week, ASCO in Focus

Legend Biotech Heads Into Monday After a Rough Week, ASCO in Focus

Legend Biotech shares are on a four-day losing streak on Nasdaq as the new week begins. Investors are watching for a Sunday evening cancer conference event that could be key for the stock’s direction. Legend Biotech shares ended Friday at $27.16, losing 3.89% on the session. The stock is now trading about 7.5% lower than the previous Friday’s close of $29.37. U.S. markets saw a shortened week due to the Memorial Day holiday. Nasdaq is closed Sundays and trades Monday to Friday, 9:30 a.m. to 4 p.m. ET.
May 31, 2026
Ascent Industries Stock Faces a June Test After Russell 3000 Deletion Notice

Ascent Industries Stock Faces a June Test After Russell 3000 Deletion Notice

Ascent Industries Co. heads into the new week with a fresh index overhang after FTSE Russell’s May 29 preliminary deletion list named the specialty chemicals maker for removal from the Russell 3000 Index. The list classifies Ascent under basic materials and identifies the ticker ACNT among projected deletions. U.S. cash equities are closed on Sunday, and Nasdaq’s regular session runs Monday through Friday from 9:30 a.m. to 4:00 p.m. Eastern Time. In the last session, Ascent closed at $13.55 on Friday, down 0.4% on the day and 6.2% from its May 22 close of $14.45 in a Memorial Day-shortened trading week.
May 31, 2026
Cirrus Logic Stock Just Stumbled. The Apple Question Comes Next

Cirrus Logic Stock Just Stumbled. The Apple Question Comes Next

Cirrus Logic Inc. heads into June with its shares off the top of a choppy, holiday-shortened week: CRUS closed Friday at $169.95, down 2.51%, and down about 0.7% from its May 22 close after touching $180.42 on Wednesday. That matters now because the next trade comes with the stock still near the high end of a 52-week range of $92.02 to $180.42. Investors have an Apple story, an earnings story and a diversification story. They now need the chart to hold up.
May 31, 2026
Altisource Rises in Holiday Week, But Customer Concerns Linger

Altisource Rises in Holiday Week, But Customer Concerns Linger

Altisource Portfolio Solutions S.A. finished the shortened week with an 8% gain over last Friday, despite giving up ground at the end. ASPS shares closed Friday at $6.52, off 3.3% on volume of 13,350 shares. Trading was thin on Nasdaq. Traders noticed the move with few new operating updates to go on. Investors mainly weighed small-cap trends, mortgage data, and recent company filings as the U.S. session heads toward June.
May 31, 2026
Intel Drops 5%, Raising Pressure on AI Rebound

Intel Drops 5%, Raising Pressure on AI Rebound

Intel Corp. slipped 5.1% to finish Friday at $114.68, trailing the broader U.S. market, which closed the week at highs. The chip giant's turnaround narrative remains full of players heading into June. Timing is key here. Nasdaq trading is closed for the weekend. The previous week was also shorter, with the Memorial Day market holiday on May 25. That means investors have time to rethink Intel before markets open again Monday.
May 31, 2026
GDS Stock Gains, but There’s a Catch to the AI Data Center Surge

GDS Stock Gains, but There’s a Catch to the AI Data Center Surge

GDS Holdings’ U.S. ADRs edged up into the weekend. Shares got some help from a firm Nasdaq session and the Hong Kong line showing a bounce. The gain was minor, not enough to make up earlier losses. GDS Holdings’ ADRs ended about 12% lower than they were on May 19, before Q1 earnings sent the stock tumbling. That’s the main issue now. Investors are into the AI demand angle but aren’t sure when that will actually turn into billable sales.
May 30, 2026
1 23 24 25 26 27 244